Agnès Bonnin

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

Rémy Duléry, Razan Mohty, Myriam Labopin et al. · JACC CardioOncology · 2021 · 139 citations · Full text

Medicine, Cardiology, Hematology +16

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 136 citations · Full text

Life Sciences, Hematology, Immunology +14

Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation

Rémy Duléry, Florent Malard, Éolia Brissot et al. · Bone Marrow Transplantation · 2023 · 31 citations · Full text

Medicine, Hematology, Immunology +17

Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study

Adrien Picod, Agnès Bonnin, Giorgia Battipaglia et al. · Biology of Blood and Marrow Transplantation · 2018 · 28 citations · Full text

Medicine, Hematology, Pediatrics +9

Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes

Nicolas Stocker, Myriam Labopin, Ines Boussen et al. · Bone Marrow Transplantation · 2019 · 28 citations

Life Sciences, Hematology, Immunology +15